Nieuwe Genomische Technieken en Resistentieveredeling

This year, the European Parliament adopted new regulations on the use of New Genomic Techniques (NGT) to develop crop varieties that are more resilient to climate change and pests, while reducing dependence on pesticides. CRISPR-Cas is one of the techniques that enables plant breeders to develop disease-resistant varieties. But will it truly provide the long-awaited solution to many plant diseases?

During this meeting, jointly organized by the Study Group for Plant Breeding and the Royal Netherlands Society of Plant Pathology (KNPV), several experts will provide an in-depth overview of the topic. How does CRISPR-Cas work, and what different forms does it take? What has changed under the new EU regulations? Who owns the patents to the CRISPR-Cas technology, and what are the practical implications? Have breeding companies already begun using the technology, and when can we expect the first commercially available plants? The meeting will conclude with a panel discussion on (amongst other topics) the societal acceptance of these new technologies.

Presentations by:
Jillis Grubben, Researcher Plant Genome Editing, Wageningen University & Research
Sjoerd Bijl, policy specialist in intellectual property, Plantum
Ania Lukasiewicz, researcher plant breeding and gene editing, Wageningen University & Research
Laurens Kroon, head of research, Bejo Zaden BV